Cargando…

Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study

BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Juan, Sun, Kexin, Wang, Jian, He, Yutong, Li, Daojuan, Liu, Shuzheng, Huang, Yunchao, Zhang, Min, Song, Bingbing, Liao, Xianzhen, Liang, He, Zhang, Qian, Shi, Mumu, Guo, Lanwei, Zhou, Yongchun, Lin, Yanping, Lu, Yanni, Tuo, Jiyu, Xia, Yafen, Sun, Huixin, Xiao, Haifan, Ji, Yong, Yan, Ci, Qiao, Jinwan, Zeng, Hongmei, Zheng, Rongshou, Zhang, Siwei, Liu, Shaoyan, Chang, Sheng, Wei, Wenqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554273/
https://www.ncbi.nlm.nih.gov/pubmed/36249201
http://dx.doi.org/10.3389/fpubh.2022.974359
_version_ 1784806656184418304
author Zhu, Juan
Sun, Kexin
Wang, Jian
He, Yutong
Li, Daojuan
Liu, Shuzheng
Huang, Yunchao
Zhang, Min
Song, Bingbing
Liao, Xianzhen
Liang, He
Zhang, Qian
Shi, Mumu
Guo, Lanwei
Zhou, Yongchun
Lin, Yanping
Lu, Yanni
Tuo, Jiyu
Xia, Yafen
Sun, Huixin
Xiao, Haifan
Ji, Yong
Yan, Ci
Qiao, Jinwan
Zeng, Hongmei
Zheng, Rongshou
Zhang, Siwei
Liu, Shaoyan
Chang, Sheng
Wei, Wenqiang
author_facet Zhu, Juan
Sun, Kexin
Wang, Jian
He, Yutong
Li, Daojuan
Liu, Shuzheng
Huang, Yunchao
Zhang, Min
Song, Bingbing
Liao, Xianzhen
Liang, He
Zhang, Qian
Shi, Mumu
Guo, Lanwei
Zhou, Yongchun
Lin, Yanping
Lu, Yanni
Tuo, Jiyu
Xia, Yafen
Sun, Huixin
Xiao, Haifan
Ji, Yong
Yan, Ci
Qiao, Jinwan
Zeng, Hongmei
Zheng, Rongshou
Zhang, Siwei
Liu, Shaoyan
Chang, Sheng
Wei, Wenqiang
author_sort Zhu, Juan
collection PubMed
description BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database. RESULTS: A total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients ≥45 years old, males (OR = 1.76, 95%CI 1.17–2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38–2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001). CONCLUSIONS: Unique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns.
format Online
Article
Text
id pubmed-9554273
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95542732022-10-13 Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study Zhu, Juan Sun, Kexin Wang, Jian He, Yutong Li, Daojuan Liu, Shuzheng Huang, Yunchao Zhang, Min Song, Bingbing Liao, Xianzhen Liang, He Zhang, Qian Shi, Mumu Guo, Lanwei Zhou, Yongchun Lin, Yanping Lu, Yanni Tuo, Jiyu Xia, Yafen Sun, Huixin Xiao, Haifan Ji, Yong Yan, Ci Qiao, Jinwan Zeng, Hongmei Zheng, Rongshou Zhang, Siwei Liu, Shaoyan Chang, Sheng Wei, Wenqiang Front Public Health Public Health BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database. RESULTS: A total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients ≥45 years old, males (OR = 1.76, 95%CI 1.17–2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38–2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001). CONCLUSIONS: Unique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns. Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9554273/ /pubmed/36249201 http://dx.doi.org/10.3389/fpubh.2022.974359 Text en Copyright © 2022 Zhu, Sun, Wang, He, Li, Liu, Huang, Zhang, Song, Liao, Liang, Zhang, Shi, Guo, Zhou, Lin, Lu, Tuo, Xia, Sun, Xiao, Ji, Yan, Qiao, Zeng, Zheng, Zhang, Liu, Chang and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Zhu, Juan
Sun, Kexin
Wang, Jian
He, Yutong
Li, Daojuan
Liu, Shuzheng
Huang, Yunchao
Zhang, Min
Song, Bingbing
Liao, Xianzhen
Liang, He
Zhang, Qian
Shi, Mumu
Guo, Lanwei
Zhou, Yongchun
Lin, Yanping
Lu, Yanni
Tuo, Jiyu
Xia, Yafen
Sun, Huixin
Xiao, Haifan
Ji, Yong
Yan, Ci
Qiao, Jinwan
Zeng, Hongmei
Zheng, Rongshou
Zhang, Siwei
Liu, Shaoyan
Chang, Sheng
Wei, Wenqiang
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title_full Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title_fullStr Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title_full_unstemmed Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title_short Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
title_sort clinicopathological and surgical comparisons of differentiated thyroid cancer between china and the usa: a multicentered hospital-based study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554273/
https://www.ncbi.nlm.nih.gov/pubmed/36249201
http://dx.doi.org/10.3389/fpubh.2022.974359
work_keys_str_mv AT zhujuan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT sunkexin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT wangjian clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT heyutong clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT lidaojuan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT liushuzheng clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT huangyunchao clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zhangmin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT songbingbing clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT liaoxianzhen clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT lianghe clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zhangqian clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT shimumu clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT guolanwei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zhouyongchun clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT linyanping clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT luyanni clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT tuojiyu clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT xiayafen clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT sunhuixin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT xiaohaifan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT jiyong clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT yanci clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT qiaojinwan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zenghongmei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zhengrongshou clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT zhangsiwei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT liushaoyan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT changsheng clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy
AT weiwenqiang clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy